Lassmann-Vague

Lassmann-Vague V, SanMarco M, LeJeune PJ, Alessis C, Vague P, Belicar P. Autoimmunity and intraperitoneal insulin treatment by programmable pumps lack of relationship. Diabetes Care 1998 21 (11 ) 2041 —4. 

Behcar P, Lassmann-Vague V. Local adverse events associated with long-term treatment by implantable insulin... 

Lassmann-Vague, V., Raccah, D., 2006. Alternatives routes of insuhn delivery. Diabetes and Metabolism 32, 513—522. 

Three long-term studies have been conducted to evaluate reliability of intranasal insulin treatment (Salzman et ah, 1985 Frauman et ah, 1987a Lassmann-Vague et ah, 1988). Drop-out rate in two of the studies was 30% due to inadequate glycemic control, and one patient developed chronic rhinitis which disappeared when subcutaneous therapy was resumed (Lass-mann-Vagueeta/., 1988). 

Nasal delivery of peptide and proteins has recently been reviewed by Pontiroli and Pozza (1990), Su (1991), Lassmann-Vague (1991), and Edman and Bjork (1992). 

Lassmann-Vague, V., 1991, The intranasal route for insulin administration, in Biotechnology of Insulin Therapy Q. C. Pickup, ed.), Blackwell Scientific, Oxford, pp. 113-125. 

Lassmann-Vague, V., Thiers, D., Vialettes, B., and Vague, P., 1988, Preprandial intranasal... 

---